Testing the glutamate hypothesis of schizophrenia
Author:
- Joshua A GordonJGJoshua A Gordon
- 1 January 2010
- journal article
- Published by Springer Nature in Nature Neuroscience
- Vol. 13 (1) , 2-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypesNature Neuroscience, 2009
- Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophreniaGenes, Brain and Behavior, 2009
- Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorderClinical Therapeutics, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- Adverse Effects of Risperidone on Spatial Working Memory in First-Episode SchizophreniaArchives of General Psychiatry, 2006
- Cognitive Dysfunction in SchizophreniaArchives of Neurology, 2006
- Glutamate and Schizophrenia: Beyond the Dopamine HypothesisCellular and Molecular Neurobiology, 2006
- Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor functionBehavioural Brain Research, 2004
- Effects of NMDA Receptor Antagonists: Implications for the Pathophysiology of SchizophreniaArchives of General Psychiatry, 2002
- GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar DisorderNeuropsychopharmacology, 2001